Current state of cancer genomics in Africa

Rethinking access to cancer care across African health systems

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

The human crisis in cancer: a Lancet Oncology Commission

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

Post-treatment exercise programme improves survival for stage II/III colon cancer

MS-553 shows promise in treating chronic lymphocytic leukaemia

Key insights on breast cancer in Cape Verde

Addressing cancer control challenges in Africa